Invitae Corporation
NVTA
NVTA was delisted on the 5th of February, 2024.
183 hedge funds and large institutions have $1.66B invested in Invitae Corporation in 2019 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 66 increasing their positions, 37 reducing their positions, and 22 closing their positions.
191% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 22
162% more capital invested
Capital invested by funds: $633M → $1.66B (+$1.03B)
78% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 37
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
37% more call options, than puts
Call options by funds: $11.8M | Put options by funds: $8.58M
29% more funds holding
Funds holding: 142 → 183 (+41)
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$10.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.68M |
| 3 |
State Street
Boston,
Massachusetts
|
-$8.58M |
| 4 |
Millennium Management
New York
|
-$7.48M |
| 5 |
DM
Deerfield Management
New York
|
-$4.85M |
NVTA Hedge Fund Activity: Q1 2019 in Review
183 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Invitae Corporation (NVTA) for Q1 2019, worth a combined $1.66B — up 162% from $633M a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new NVTA positions and 22 closed out — a net gain of 42 holders — while 66 added to existing stakes and 37 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $32.5M. The largest seller was OrbiMed, cutting an estimated $10.6M.
- 183 institutional investors held Invitae Corporation (NVTA) as of Q1 2019, up from 142 in Q4 2018.
- Funds reported $1.66B of Invitae Corporation stock for Q1 2019, up 162% quarter-over-quarter.
- 64 funds opened new Invitae Corporation positions in Q1 2019 and 22 closed out, a net change of +42 holders.
- The largest Invitae Corporation buyer in Q1 2019 was AllianceBernstein, an estimated $32.5M added.
- The largest Invitae Corporation seller in Q1 2019 was OrbiMed, an estimated $10.6M sold.
Based on aggregated 13F filings for Q1 2019.